We are live on ! Find out more
CANC icon

Tema Oncology ETF

15 hedge funds and large institutions have $20.8M invested in Tema Oncology ETF in 2026 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

25% more funds holding

Funds holding: 1215 (+3)

3.53% less ownership

Funds ownership: 13.99%10.46% (-3.5%)

11% less capital invested

Capital invested by funds: $23.5M → $20.8M (-$2.63M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
15
Holders Change
+3
Holders Change %
+25%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
6
Increased
6
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change

CANC Hedge Fund Activity: Q2 2026 in Review

15 of the 8,220 institutional investors tracked by Wall St. Rank reported a position in Tema Oncology ETF (CANC) for Q2 2026, worth a combined $20.8M — down 11% from $23.5M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CANC positions and 2 closed out — a net gain of 4 holders — while 6 added to existing stakes and 1 trimmed.

The largest buyer was Thrivent Financial for Lutherans, adding an estimated $1.52M. The largest seller was Citadel Advisors, exiting entirely with an estimated $2.54M sold.

  • 15 institutional investors held Tema Oncology ETF (CANC) as of Q2 2026, up from 12 in Q1 2026.
  • Funds reported $20.8M of Tema Oncology ETF stock for Q2 2026, down 11% quarter-over-quarter.
  • 6 funds opened new Tema Oncology ETF positions in Q2 2026 and 2 closed out, a net change of +4 holders.
  • The largest Tema Oncology ETF buyer in Q2 2026 was Thrivent Financial for Lutherans, an estimated $1.52M added.
  • The largest Tema Oncology ETF seller in Q2 2026 was Citadel Advisors, an estimated $2.54M sold.

Based on aggregated 13F filings for Q2 2026.